Delcath Systems
Delcath Systems Logo
About Delcath Systems
Delcath Systems Inc is a commercial-stage interventional oncology company specializing in the development and commercialization of medical devices and drug-device combination products for the treatment of primary and metastatic liver cancers. Its lead products include the HEPZATO KIT, a hepatic delivery system for administering high-dose chemotherapy to the liver, and the CHEMOSAT Hepatic Delivery System, available in Europe. Delcath's solutions are designed to provide targeted, minimally-invasive treatments for liver cancer patients in the United States and Europe.
Address
1633 Broadway, 22nd Floor Suite C
New York, 10019
United States
Year founded
1988
Number of employees
0-100
Sector
Health Care
Industry Group
Health Care Equipment & Services
Industry
Health Care Equipment & Supplies
Subindustry
Health Care Equipment
Report inaccurate data
Request an update to help us keep the brand up-to-date.
